The Offer

The goal of the Biomaterials Development Center is to reduce implant related infections by bringing a number of innovative infection-resistant biomaterials (or coatings) to clinical application

By formulating long-term, exclusive public-private partnerships with medical device or material companies, we can bring infection-resistant biomaterials to clinical practice. Together we can overcome many of the key issues that have previously resulted in biomaterials being lost in translation from bench to bed (clinical application).

By combining the extensive knowledge, facilities and resources of the BDC together with the market knowledge, engineering skills and resources of a proven medical device/polymer company, we can jointly develop new infection-resistant materials and bring them to clinical application.

The website of BDC uses functional and anonymous analytics cookies. By continuing on this website and/or closing this message you accept this cookies!